Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesOn Demand: Webinars
Conference Coverage Conference Listing
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
Advocacy GroupsArt GalleryClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story
Subscribe
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
Immunotherapy
LeukemiaLeukemiaLeukemia
Lung CancerLung Cancer
LymphomaLymphomaLymphomaLymphomaLymphoma
Myeloma
Rare CancersRare CancersRare CancersRare Cancers
Sarcoma
Skin CancerSkin Cancer
Thyroid Cancer
Spotlight -
  • Blogs
  • Breast Cancer Webinar Series
  • Cancer Horizons
  • Clinical Trial Corner
  • Heal®
  • Publications
  • Videos
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
Immunotherapy
LeukemiaLeukemiaLeukemia
Lung CancerLung Cancer
LymphomaLymphomaLymphomaLymphomaLymphoma
Myeloma
Rare CancersRare CancersRare CancersRare Cancers
Sarcoma
Skin CancerSkin Cancer
Thyroid Cancer
    • Subscribe
Advertisement

Article

February 13, 2023

Cancer-Related Unemployment Can Decrease Quality of Life

Author(s):

Colleen Moretti

Patients who are financially struggling due to job loss after a cancer diagnosis may benefit from multidisciplinary back-to-work programs and financial counseling, according to an expert.

Patients with brain or spinal tumors who are unemployed due to their disease reported more symptoms of depression and anxiety, compared with counterparts who were employed, according to recent study results.

“This highlights that we need to take care of the person living with the cancer and not just the cancer,” said. Dr. Heather Leeper, lead author on the study and assistant professor at the University of Chicago, in an interview with CURE®.

The goal of the study — which was published in the journal Neurology — was to evaluate how being unemployed due to the disease, impacted quality of life in patients with brain and spinal tumors.

“We thought that those issues were important because if individuals are no longer able to work, we realized that had economic implications in terms of not only not having income, but then they also potentially have lost access to employer-based insurance, which is a major factor for being insured here in the United States, given that there's no national health service,” Leeper said.

She also added that people go to work for more reasons than just financial. They might be doing something they are passionate about or finding a sense of purpose.

READ MORE: On Cancer and Careers: How a Diagnosis Changed Survivors’ Jobs

The study included 277 patients, and notably, those who were Hispanic were 2.3 times more likely in the overall group to report unemployment, and 3.2 times more likely in the brain tumor group.

Those 77 individuals (28%) who reported unemployment in the overall group also reported more functional impairment with walking, washing, dressing, preforming usual activities and a declined health-related quality of life.

Moreover, patients who were unemployed reported more moderate to severe depressive (25%) and anxiety symptoms (30%) than those who were employed (8%; 15%, respectively).

Patients with brain tumors who were unemployed reported, on average, three more symptoms as moderate to severe compared to those employed.

“I would love for patients to be able to read this work and know that they have a voice to bring to their providers and ask ‘What else can I be doing to improve my function to make my quality of life better?’” Leeper said.

How Patients Can Take Action

For those who are struggling due to unemployment after a cancer diagnosis, Leeper recommends searching for a “return-to-work program,” with a multidisciplinary approach — which may include additional physical, occupational and/or speech therapy.

“It does seem that there have been return-to-work programs that are multidisciplinary that show in research that patients who participate in those programs are able to return to work at much higher rates than people who just have physical therapy or just have occupational therapy — meaning that it takes a multidisciplinary approach to be able to give these patients the support they need to resume going back to work,” she said.

Some patients might also look into a different job position or field than the one they had prior to a cancer diagnosis. Cancer can impact both physical and cognitive impacts on patients, so if they had a job with high physical demand, they may not be able to do that anymore, but could excel elsewhere; and the same goes for a job with a high cognitive demand.

And for those who are struggling in a financial aspect, they may benefit from financial counseling. This can provide support in understanding health insurance, pharmacy means, medical bills and how to obtain health insurance if a patient doesn’t have it or will soon not have it because of the inability to return back to work.

“I think the next thing that we within clinical research need to do a better job on is an ongoing basis to understand the needs of patients and understand how we can connect people with the resources that they need, when they are not able to,” Leeper concluded.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Image of Dr. Merrell
The field of radiation oncology has advanced in brain cancer treatment with precise therapeutic approaches including proton and carbon therapy.
Adolescent and Young Adult Cancer Awareness Week sheds light on the financial hardships young cancer survivors face, including debt and limited assistance.
Image of woman.
Registered nurse Patricia Jakel emphasizes the importance of educating patients on evolving breast cancer research and the need for routine screenings.
Dr. Anna Arthur is the Director of the Medical Nutrition Science Program, as well as a tenure-track Assistant Professor in the Department of Dietetics and Nutrition at the University of Kansas Medical Center.
Kate, Princess of Wales, ‘Got So Attached’ to Her Port During Cancer Treatment
Dr. Michael Bogenschutz
Dr. Stephanie Alice Baker
Dr. Michael Bogenschutz, director of the NYU Langone Center for Psychedelic Medicine in New York,
Related Content
Advertisement
Younger patients with grade 3 oligodendroglioma have fewer molecular abnormalities and longer survival than older patients: © stock.adobe.com.
May 19th 2025

Study Reveals Distinct Outcomes in Younger Patients With Grade 3 Oligodendroglioma

Spencer Feldman
Younger patients with grade 3 oligodendroglioma have fewer molecular abnormalities and longer survival than older patients, a study found.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
Danyelza is now a recommended treatment in NCCN guidelines for high-risk neuroblastoma: © sudok1 - stock.adobe.com.
May 8th 2025

Danyelza Added to NCCN Guidelines for High-Risk Neuroblastoma

Spencer Feldman
Danyelza is now a recommended treatment in NCCN guidelines for relapsed or refractory high-risk neuroblastoma, a type of brain cancer.
‘Jeopardy!’ Champion Christine Whelchel Recalls Why She Removed Her Wig on National TV
June 30th 2022

‘Jeopardy!’ Champion Christine Whelchel Recalls Why She Removed Her Wig on National TV

Sailaja Darisipudi Darlene Dobkowski, MA
In less than a year, Christine Whelchel went from receiving a diagnosis of breast cancer to becoming a trailblazing “Jeopardy!” champion.
Illustration of brain.
April 30th 2025

Larger Tumor Size Linked to Higher Mortality Risk in Brain Cancer

Ryan Scott
Investigators shared real-world data showing a clear and consistent association between increased tumor size and mortality for patients with brain cancer.
FDA sign.
April 23rd 2025

FDA Grants Breakthrough Status to CAR-T Therapy for Pediatric Brain Tumor

Ryan Scott
The FDA granted breakthrough therapy designation to an autologous CAR-T cell therapy for pediatric patients with diffuse intrinsic pontine glioma.
Related Content
Advertisement
Younger patients with grade 3 oligodendroglioma have fewer molecular abnormalities and longer survival than older patients: © stock.adobe.com.
May 19th 2025

Study Reveals Distinct Outcomes in Younger Patients With Grade 3 Oligodendroglioma

Spencer Feldman
Younger patients with grade 3 oligodendroglioma have fewer molecular abnormalities and longer survival than older patients, a study found.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
Danyelza is now a recommended treatment in NCCN guidelines for high-risk neuroblastoma: © sudok1 - stock.adobe.com.
May 8th 2025

Danyelza Added to NCCN Guidelines for High-Risk Neuroblastoma

Spencer Feldman
Danyelza is now a recommended treatment in NCCN guidelines for relapsed or refractory high-risk neuroblastoma, a type of brain cancer.
‘Jeopardy!’ Champion Christine Whelchel Recalls Why She Removed Her Wig on National TV
June 30th 2022

‘Jeopardy!’ Champion Christine Whelchel Recalls Why She Removed Her Wig on National TV

Sailaja Darisipudi Darlene Dobkowski, MA
In less than a year, Christine Whelchel went from receiving a diagnosis of breast cancer to becoming a trailblazing “Jeopardy!” champion.
Illustration of brain.
April 30th 2025

Larger Tumor Size Linked to Higher Mortality Risk in Brain Cancer

Ryan Scott
Investigators shared real-world data showing a clear and consistent association between increased tumor size and mortality for patients with brain cancer.
FDA sign.
April 23rd 2025

FDA Grants Breakthrough Status to CAR-T Therapy for Pediatric Brain Tumor

Ryan Scott
The FDA granted breakthrough therapy designation to an autologous CAR-T cell therapy for pediatric patients with diffuse intrinsic pontine glioma.
About Us
Advertise / Support
Editorial Board
Contact Us
CancerNetwork.com
TargetedOnc.com
OncLive.com
OncNursingNews.com
Terms & Conditions
Privacy
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.